| Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma D Sturm, H Witt, V Hovestadt, DA Khuong-Quang, DTW Jones, ... Cancer cell 22 (4), 425-437, 2012 | 1216 | 2012 |
| DNA methylation-based classification of central nervous system tumours D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ... Nature 555 (7697), 469-474, 2018 | 530 | 2018 |
| Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups KW Pajtler, H Witt, M Sill, DTW Jones, V Hovestadt, F Kratochwil, K Wani, ... Cancer cell 27 (5), 728-743, 2015 | 512 | 2015 |
| Epigenomic alterations define lethal CIMP-positive ependymomas of infancy SC Mack, H Witt, RM Piro, L Gu, S Zuyderduyn, AM Stütz, X Wang, ... Nature 506 (7489), 445-450, 2014 | 426 | 2014 |
| New brain tumor entities emerge from molecular classification of CNS-PNETs D Sturm, BA Orr, UH Toprak, V Hovestadt, DTW Jones, D Capper, M Sill, ... Cell 164 (5), 1060-1072, 2016 | 386 | 2016 |
| Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma H Witt, SC Mack, M Ryzhova, S Bender, M Sill, R Isserlin, A Benner, ... Cancer cell 20 (2), 143-157, 2011 | 374 | 2011 |
| DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis F Sahm, D Schrimpf, D Stichel, DTW Jones, T Hielscher, S Schefzyk, ... The lancet oncology 18 (5), 682-694, 2017 | 225 | 2017 |
| Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma B Wiestler, D Capper, M Sill, DTW Jones, V Hovestadt, D Sturm, ... Acta neuropathologica 128 (4), 561-571, 2014 | 168 | 2014 |
| Large-scale radiomic profiling of recurrent glioblastoma identifies an imaging predictor for stratifying anti-angiogenic treatment response P Kickingereder, M Götz, J Muschelli, A Wick, U Neuberger, RT Shinohara, ... Clinical Cancer Research 22 (23), 5765-5771, 2016 | 135 | 2016 |
| Radiogenomics of glioblastoma: machine learning–based classification of molecular characteristics by using multiparametric and multiregional MR imaging features P Kickingereder, D Bonekamp, M Nowosielski, A Kratz, M Sill, S Burth, ... Radiology 281 (3), 907-918, 2016 | 133 | 2016 |
| Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies C Schröder, A Jacob, S Tonack, TP Radon, M Sill, M Zucknick, S Rüffer, ... Molecular & cellular proteomics 9 (6), 1271-1280, 2010 | 101 | 2010 |
| Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles A Hölsken, M Sill, J Merkle, L Schweizer, M Buchfelder, J Flitsch, ... Acta neuropathologica communications 4 (1), 20, 2016 | 85 | 2016 |
| Robust biclustering by sparse singular value decomposition incorporating stability selection M Sill, S Kaiser, A Benner, A Kopp-Schneider Bioinformatics 27 (15), 2089-2097, 2011 | 78 | 2011 |
| Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations A Reinhardt, D Stichel, D Schrimpf, F Sahm, A Korshunov, DE Reuss, ... Acta neuropathologica 136 (2), 273-291, 2018 | 65 | 2018 |
| Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma P Kickingereder, U Neuberger, D Bonekamp, PL Piechotta, M Götz, ... Neuro-oncology 20 (6), 848-857, 2018 | 65 | 2018 |
| Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA … B Wiestler, D Capper, V Hovestadt, M Sill, DTW Jones, C Hartmann, ... Neuro-oncology 16 (12), 1630-1638, 2014 | 65 | 2014 |
| Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience D Capper, D Stichel, F Sahm, DTW Jones, D Schrimpf, M Sill, S Schmid, ... Acta neuropathologica 136 (2), 181-210, 2018 | 64 | 2018 |
| Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas KW Pajtler, J Wen, M Sill, T Lin, W Orisme, B Tang, JM Hübner, ... Acta neuropathologica 136 (2), 211-226, 2018 | 53 | 2018 |
| Drug-perturbation-based stratification of blood cancer S Dietrich, M Oleś, J Lu, L Sellner, S Anders, B Velten, B Wu, J Hüllein, ... The Journal of clinical investigation 128 (1), 427-445, 2018 | 53 | 2018 |
| Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma LM Hoffman, AM Donson, I Nakachi, AM Griesinger, DK Birks, V Amani, ... Acta neuropathologica 127 (5), 731-745, 2014 | 50 | 2014 |
Stefan M. PfisterProfessor of Pediatrics, Hopp-Children´s Cancer Center Heidelberg (KiTZ)Verified email at kitz-heidelberg.de
